Level of sICAM-1 in Patients with Acute Ischemic Cerebrovascular Disease and Its Significance / 中国医师杂志

Objective To explore the level of soluble intercellular adhension molecule-1 (sICAM-1) in the patients with acute ischemic cerebrovascular disease (AICVD) and its clinical significance. Methods The level of sICAM-1 was determined by double-antibody enzyme linked immunosorbent in 67 patients with AICVD and 45 patients being susceptible to AICVD. 40 healthy subjects served as normal control group. Results The level of sICAM-1 in the patients with AICVD was significantly higher than that in the patients being susceptible to AICVD (P